Home Cart Sign in  
Chemical Structure| 558447-26-0 Chemical Structure| 558447-26-0

Structure of Mavorixafor
CAS No.: 558447-26-0

Chemical Structure| 558447-26-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AMD-070 is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay, and inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs.

Synonyms: AMD-070; AMD 11070; X4P-001

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mavorixafor

CAS No. :558447-26-0
Formula : C21H27N5
M.W : 349.47
SMILES Code : NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]3CCCC4=C3N=CC=C4
Synonyms :
AMD-070; AMD 11070; X4P-001
MDL No. :MFCD11977316

Safety of Mavorixafor

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Mavorixafor

GPCR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nu-nu mice Subcutaneous transplant tumor model Intraperitoneal injection 1 mg/kg body weight Once a week for 4 weeks To investigate the effect of CXCR4 antagonists on the tumor growth of GEM-R PaCa cells. Results showed that GEM significantly enhanced the tumor growth of GEM-R PaCa cells, and CXCR4 antagonists significantly inhibited this enhancement. BMC Cancer. 2016 May 12;16:305
C57Bl/6 J female mice HSC mobilization model I.p. injection 5 mg/kg Single injection for 1 h To compare the effects of plerixafor and AMD11070 on HSC and neutrophil mobilization, finding that plerixafor is superior Commun Biol. 2021 May 12;4(1):569
Mice Bleomycin-induced pulmonary fibrosis model Oral gavage (PO) 400μg/mouse Daily for 21 consecutive days To evaluate the efficacy of AMD070 in a BLM-induced pulmonary fibrosis model. Results showed AMD070 had no significant effect on lung fibrosis but significantly improved survival rates. PLoS One. 2016 Mar 21;11(3):e0151765

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02680782 Healthy PHASE1 TERMINATED 2016-02-28 Covance CRU, Inc., Daytona Bea... More >>ch, Florida, 32117, United States Less <<
NCT03005327 WHIM Syndrome PHASE2 COMPLETED 2022-06-16 University of Washington Medic... More >>al Center, Seattle, Washington, 98195, United States|St. Vincent's Hospital, Fitzroy, Victoria, 3065, Australia Less <<
NCT02823405 Melanoma Phase 1 Recruiting October 2017 United States, Georgia ... More >> Clinical Site Recruiting Atlanta, Georgia, United States, 30322 United States, Iowa Clinical Site Recruiting Iowa City, Iowa, United States, 52242 United States, Texas Clinical Site Recruiting Houston, Texas, United States, 77030 United States, Utah Clinical Site Recruiting Salt Lake City, Utah, United States, 84112 Less <<
NCT00063804 HIV Infections Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21205 United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 98104 Less <<
NCT00089466 HIV Infections Phase 1 Phase 2 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS Birmingham, Alabama, United States, 35924-2050 United States, Georgia The Ponce de Leon Ctr. CRS Atlanta, Georgia, United States, 30308 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 46202-5250 Less <<
NCT00361101 HIV Infections ... More >> X4 Tropic Virus Less << Phase 1 Completed - United States, Florida ... More >> Orlando, Florida, United States, 32803 United Kingdom London, United Kingdom, SW10 9TH Less <<
NCT05103917 Triple Negative Breast Cancer PHASE1|PHASE2 UNKNOWN 2023-05-21 Shang hai Tumor Hospital, Shan... More >>ghai, Shang Hai, 200032, China Less <<
NCT04154488 Neutropenia PHASE1|PHASE2 COMPLETED 2024-08-27 USF Health Department of Pedia... More >>trics, Saint Petersburg, Florida, 33701, United States|University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|University of Texas, Southwestern, Dallas, Texas, 75235, United States|University of Washington, Seattle, Washington, 98195, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.86mL

0.57mL

0.29mL

14.31mL

2.86mL

1.43mL

28.61mL

5.72mL

2.86mL

References

 

Historical Records

Categories